For research use only
| Cat No. | ABC-X0026C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocyte |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The FGFR3 (G375C) BAF3 cell line provides a powerful model for studying FGFR3 activation and its impact on the ERK/MAPK pathway, advancing cancer research.
Human FGFR3 (G375C) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. FGFR3 (G375C) BAF3 mutant cell line is generated by stable integration of exogenous human FGFR3 gene harboring the G375C point mutation into Ba/F3 host cells using our optimized transduction of lentiviral vectors.
Target
FGFR3 encodes a receptor tyrosine kinase involved in skeletal development and cell signaling. The G375C mutation is located in the extracellular domain and promotes ligand-independent dimerization, contributing to constitutive activation. Such mutations are associated with skeletal dysplasia and cancers such as bladder carcinoma. AcceGen offers generation of stable overexpression and mutant-specific cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0026C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocyte |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The FGFR3 (G375C) BAF3 Cell Line serves as a powerful tool to investigate aberrant FGFR3 activation and its impact on oncogenic signaling. This model enables mechanistic studies of FGFR3-induced transformation, ERK/MAPK pathway activation, and evaluation of FGFR inhibitors. It is utilized for drug screening and validation of FGFR3-targeted therapies.